Skip to content

Clinical trials

Primary Myelofibrosis trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Country / region: Austria Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20112
20121
20131
20161
20171
20182
20191
20204
20217
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting5
Terminated5
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Incyte Corporation6
Celgene4
AbbVie2
Kartos Therapeutics, Inc.2
Sierra Oncology LLC - a GSK company2
Geron Corporation1
GlaxoSmithKline1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis26
Myeloproliferative Disorders8
Anemia4
Neoplasms3
Thrombocytosis2
Bone Marrow Diseases1
Bronchiolitis Obliterans1
Bronchiolitis Obliterans Syndrome1
Hematologic Diseases1
Leukemia, Megakaryoblastic, Acute1

Trials

Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.